BRIEF-Hansoh Pharmaceutical Says EMA Starts Reviewing Marketing Authorization Application For Aumolertinib

4

Oct 11 (Reuters) – Hansoh Pharmaceutical Group Company Limited: * SAYS IT RESUBMITTED EU MARKETING AUTHORIZATION APPLICATION FOR AUMOLERTINIB TO EMA * SAYS EMA VALIDATED APPLICATION AND REVIEW

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)